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Abstract
Background: Patients with severe and enduring eating disorders (SEED) are seriously ill and have a low quality of
life. Case management (CM), originally developed for adult patients with severe mental disabilities, has been shown
to enhance social functioning and improve quality of life, while reducing the number and length of hospitalizations.
In 2014, a special unit based on CM, for patients with SEED (the Eira unit) was started at Stockholm Centre for Eating
Disorders, Sweden.
Method/Design: This study aims to investigate if CM can improve SEED patients’ quality of life, and reduce
their eating disorder symptoms as well as their health care consumption. Methods for data collection are a
semi-structured diagnostic interview, self-report questionnaires, and a qualitative interview. The diagnostic
interview and the self-report assessments will be done at start of treatment and at follow-ups after 1, 2, and
3years. The qualitative interview will be conducted 1 year after start of treatment. The study is approved by
the ethical review board in Stockholm in compliance with the Helsinki Declaration.
Discussion: CM is a possible new contribution to the treatment methods for SEED. It does not aim at remission, but
rather to accept life as it is, and to enhance quality of life in the presence of the ED. This study will investigate the
potential benefits of this novel intervention in a special unit for SEED patients.
Trial registration: Clinicaltrials.gov Id: NCT02897622
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Background
Patients with eating disorders (ED) are a challenge for
the health care system and the recovery from ED is often
slow. Despite massive effort some of the patients do not
recover and go on to develop a severe and enduring eat-
ing disorder (SEED). Patients with SEED have had an
ED for a long time and have often undergone numerous
treatments, either voluntarily or compulsory, without
recovering from the ED. Owing to the nature of the ED
the SEED patients remain seriously ill with severe
distress due to social impairments, physical strain and
psychiatric symptoms such as anxiety, depression and
compulsiveness [1–3]. It is also common that relatives
are affected, not only by constant concern, but also be-
cause the SEED leads to financial problems that family
members have to deal with [4]. Many patients with
SEED need long-term sick leave and are heavy con-
sumers of health care, often with long in-patient somatic
and psychiatric admissions [2, 5]. SEED patients often
feel great and complicating ambivalence towards treat-
ment [6]. Taken together these factors can contribute to
a low motivation for treatment, which probably leads to
a vicious circle that further complicates treatment and
rehabilitation [5]. In the ED field, there is a growing con-
sensus that treatment of patients with SEED needs to be
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multi-professional, with a focus on improving the pa-
tients’ social situation, minimizing medical complica-
tions, and enhancing quality of life and independence,
rather than focusing one-sided on symptom reduction
[3, 7, 8]. It is important to set mutual, acceptable and
realistic goals that can be achieved, to do this in collab-
oration with the patients, and to allow this process a
long time [9, 10]. Quality of life for patients with SEED-
AN is seriously affected [11] and is as low as the quality
of life in severely depressed and schizophrenic patients
[8]. Besides the personal suffering of patients and their
families, SEED is also associated with high costs for
health care and for society in general.
Case management (CM) is a method developed for
adult patients with severe mental disabilities such as
schizophrenia, other psychoses, personality disorders or
serious addiction problems. CM has been shown to im-
prove quality of life [12], enhance social functioning
[10], promote ability to live as independently as possible
by reducing the number and length of hospitalizations
for the patients [13]. CM efforts are individualized
and can vary in time from a few months to several
years [10]. This study will investigate the potential
benefits of such a CM intervention in a special unit
for SEED patients.
Specific aims
The aim of this study is to evaluate a CM model for
patients with SEED. Specific questions that the study
aims to explore are:
Does entering the CM program lead to:
 Improvement in patients’ quality of life?
 Reduction of patients’ ED symptoms?




At the Stockholm Centre for Eating Disorders in Sweden
a new special unit for SEED (Eira) was established in
2014. The staff at Eira consists of one doctor (part time),
one social worker and two psychiatry nurses with long
experience of ED-treatment.
Before a patient is accepted at Eira, a networking
meeting is held, in which the patient is encouraged to
bring important people, like family members, remittent
or others. Following this meeting, the decision is made
whether the patient should be accepted or not.
During the first 5–6 sessions at Eira, the patient’s
psychiatric, somatic and social condition is carefully
assessed, as well as her/his medical history and previous
treatment experiences. It is important for the case man-
ager (i.e. the social worker or one of the nurses) to know
the patient and her/his preferences and needs well, in
order to be able to coordinate the different caregivers
and authorities involved in the patient’s life. The clinical
contact between case manager and patient mainly consists
of supportive conversations. However, in the “clinical case
management” model used in Eira, the case manager also
has a treating role, for example by performing social train-
ing, somatic controls and family support. The patient’s
needs and preferences guide the frequency, place and
form of the meetings. Meetings may take place wherever
it is deemed appropriate, some meetings may even be in
the form of phone calls or text messages.
Another of the case manager’s tasks is to aid the pa-
tient in contacts with different authorities and, if neces-
sary, to help with economic issues. It is also important
to regularly monitor the patient’s somatic condition.
If the patient is temporarily in need of more intensive
somatic or psychiatric care, the case manager can help
to plan such an effort. During the period of more inten-
sive care, the case manager maintains contact with the
patient by visits and phone calls, and by participating in
meetings with the temporary caregivers.
With the patients’ consent, relatives are invited to par-
ticipate in the CM intervention. Information and support
is offered relatives on an individual basis, this also includes
underage children. Twice a year, there is also a lecture
about the SEED condition for the relatives (without
participation of the patients) at Eira. During the lecture
participants can ask questions and discuss problems they
encounter as SEED relatives.
There is no time limit for the CM intervention. The
patient is offered support as long as he/she wants it, inde-
pendent of degree of ED symptoms or medical condition.
Participants
The Eira unit can manage 30 patients simultaneously,
and all patients included in the CM intervention will be
asked to participate in the study. Eira accepts patients
who have been suffering from ED for at least 10 years
and participated in at least three failed treatment efforts
in specialized ED units. Since they have been ill for a
long time and since previous treatment efforts have been
unsuccessful, patients participating in the study will act
as their own controls.
The study is approved by the ethical review board in
Stockholm in compliance with the Helsinki Declaration.
Measures
Methods for data collection are a semi-structured diag-
nostic interview, a qualitative interview, self-report ques-
tionnaires and data from medical records. The diagnostic
interview and the self-report assessments will be done at
start of treatment and at follow-ups after 1, 2, and 3 years.
The qualitative interview will be conducted one year after
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start of treatment. Data from medical records will be
collected retrospectively.
The Structured Eating Disorder Interview (SEDI) is
a semi-structured diagnostic interview for ED diagno-
ses according to the DSM-IV. The interview consists
of a maximum of 30 and normally about 20–25
questions [14].
The RAND-36 (also known as the SF-36) measures
health-related quality of life (HRQoL) [13]. Changes in
the HRQoL over time can be seen by comparing repeated
assessments [15, 16].
The Eating Disorder Examination Questionnaire (EDE-
Q) measures central symptomatic aspects of ED by way
of patient’s self-ratings [17, 18].
The Treatment Satisfaction Scale 2 (TSS-2) is a patient-
rated assessment of treatment satisfaction in a simple 6-
item scale [19]. TSS-2 will be used at all follow-ups.
The qualitative interview is semi-structured and consists
of three broad themes:
1) The patient’s thoughts about her/his life situation
in the year he/she has been at Eira.
2) The patient’s thoughts and reflections about her/his
quality of life, and whether it has been affected in
the year he/she has been at Eira.
3) The patient’s thoughts about her/his future.
The informants will be asked to talk openly around
these themes. The interviewer, who is the same person
for all interviews, is a psychologist who is not part of the
Eira staff (Table 1).
Outcome
Primary outcome is quality of life. Secondary outcomes
are health care consumption and costs, and ED symp-
toms at 1, 2 and 3 years follow-up.
Qualitative analysis
The interview will be tape-recorded and transcribed ver-
batim. After the interview the patients will have an op-
portunity to review a transcript and to evaluate and
comment upon what has been said. The interviews will
be analysed with qualitative content analysis according
to Hsieh & Shannon [20].
Evaluation of cost-effectiveness
The cost-effectiveness analysis consists of costs of the
CM intervention, changes in quality of life, as well as so-
cietal costs such as health care usage and loss of produc-
tion. The perspective of the analysis will be societal and
the time horizon 3 years. The analysis method is going
to be cost-utility analysis with health effect expressed in
quality adjusted life years (QALY) [21]. The analysis
will be complemented with the probability of accept-
able cost-effectiveness with different willingness to pay
for a QALY [22, 23].
All costs of the CM intervention occur at Eira. The
cost for each patient in the study can be calculated by
Eira’s total cost divided with each patient’s share of
resource utilization based on enrolled time.
QALYs will be estimated based on RAND-36 trans-
formed to SF-6D based on a British preference score
[24, 25]. From the measures at baseline, and after 1, 2
and 3 years, changes in QALYs can be estimated. From
medical records, changes in cost of health care usage
can be calculated. The participants’ employment and
change acquisition work rate is followed during the same
period based on interviews with participants.
The treatment may also have impact on relatives’ quality
of life, costs and earnings. These aspects will not be
considered in the analysis.
Discussion
The treatment of patients with SEED often causes frus-
tration and confusion among ED clinicians, since these
patients often have tried “everything” without a lasting
positive effect. In our clinical experience this often re-
sults in a situation where patients are considered “un-
motivated” and dismissed from treatment, which in turn
often leads to a symptom deterioration and that patients
eventually return to the clinic in need for more acute in-
terventions. As an alternative, clinicians may continue to
offer patients interventions that neither therapist nor
patient believes is helpful – at least not in a longer per-
spective. It might be time to re-evaluate what a positive
outcome is for these patients.
CM provides an alternative to traditional treatment
aiming at symptom reduction. CM aims to improve the
patients’ quality of life, enhance their social functioning,
and promote their ability to live as independently as
possible despite their illness. CM offers unconditional
long-term support, without requiring treatment progress.
Instead CM stresses stabilization and harm-minimizing
interventions, which are assumed to both increase quality
of life and social functioning and to reduce the number
and length of hospitalizations.
There has been no similar service for patients with ED
in Sweden or, to our knowledge, anywhere else. For a
long time, CM has been used for patients with serious
Table 1 Measures over time
Measure Baseline 1 year 2 years 3 years
SEDI X X X X
RAND-36 X X X X
EDE-Q X X X X
TSS-2 X X X
Interview X
Molin et al. Journal of Eating Disorders  (2016) 4:24 Page 3 of 5
mental disabilities, such as schizophrenia, other psych-
oses or personality disorders, as well as for serious sub-
stance abuse problems. Since previous studies have
shown similarities between SEED patients and patients
with schizophrenia [2], it is reasonable to think that CM
can be helpful also for SEED. However, we stress that
CM is not an intervention for patients with a short dur-
ation of illness. For these patients, full recovery should
be the main focus. It is also important to point out that
CM is not to be seen as a “last resort” or as palliative
care. The patients’ goals, life situation and abilities must
always be the guiding principle in any intervention, and
an important task for the case manager is to always keep
an open dialogue with the patients. Although the pa-
tients previously have not had a lasting effect of any
treatment interventions, this is never to be seen as a
“failure”. At another time, in another life situation, the
conditions may be better. One of the case managers’
tasks is to guide and help the patients to get access to
the right intervention at the right time, and to create the
best possible conditions for this intervention.
The primary outcome of this study is quality of life,
which will be measured with both quantitative and
qualitative measures. It is important to learn more about
how SEED patients define quality of life. Is it to have
fewer ED symptoms? Better economy? Or is it to be at
peace with the ED, without the risk of becoming somat-
ically too ill? Secondary outcome measures are ED diag-
nosis, ED symptoms, treatment satisfaction and health
care consumption. In terms of ED diagnosis, there is no
goal of remission with the support of CM. However, it is
important to monitor any changes in ED diagnosis and
symptoms over time.
The patients’ acceptance of CM at Eira will also be
followed up with both quantitative and qualitative mea-
sures, to gain an understanding of the patients’ thoughts
about the intervention. Perhaps CM will impact the
SEED patients’ positively, but there is also a risk that pa-
tients will feel more vulnerable and alone when active
treatment to reduce symptoms or pushing for weight
gain is terminated.
The entire study is uncontrolled and compares con-
ditions before and during the intervention based on
an assumption that no changes would occur without
the intervention. This assumption creates uncertainty
and the sensitivity analysis is therefore particularly
important. Especially sensitive to external influences
are healthcare usage and productions costs will be
considered. They can be affected by changes in the
health care organization, enrolment principles and
changes in the labour market. Therefore, these condi-
tions will be specifically studied, and in the sensitivity
analysis cost-effectiveness will also be estimated with-
out those possible benefits.
In summary, it is our hope that CM, despite its seemingly
limited ambitions, will prove to improve living conditions
for SEED patients as well as to reduce society’s cost.
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